ResMed Announces Participation in the 38th Annual J.P. Morgan Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--Jan 6, 2020--
ResMed (NYSE: RMD, ASX: RMD) today announced that Mick Farrell, chief executive officer, will present at the 38 th Annual J.P. Morgan Annual Healthcare Conference on Monday, January 13, 2020, beginning at approximately 8:30 a.m. (Pacific Standard Time) at Westin St. Francis in San Francisco, CA.
More information about this event, including a live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be available approximately one hour after the live webcast ends and will be accessible for approximately 90 days following the conference.
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200106005001/en/
CONTACT: For investors
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: NURSING DATA MANAGEMENT TECHNOLOGY MANAGED CARE OTHER HEALTH HEALTH GENERAL HEALTH OTHER TECHNOLOGY MEDICAL DEVICES SOFTWARE HOSPITALS
Copyright Business Wire 2019.
PUB: 01/06/2020 09:00 AM/DISC: 01/06/2020 09:01 AM